Holen Sie sich die Stockscreener-App
58.76
3.00%
1.71
Handel nachbörslich:
58.76
Schlusskurs vom Vortag:
$57.05
Offen:
$57.3
24-Stunden-Volumen:
751.48K
Relative Volume:
0.82
Marktkapitalisierung:
$3.25B
Einnahmen:
$249.12M
Nettoeinkommen (Verlust:
$-90.19M
KGV:
-34.56
EPS:
-1.7
Netto-Cashflow:
$-88.21M
1W Leistung:
+1.29%
1M Leistung:
-2.42%
6M Leistung:
-14.12%
1J Leistung:
-14.96%
1-Tages-Spanne:
$56.02
$59.10
1-Wochen-Bereich:
$55.76
$62.17
52-Wochen-Spanne:
$47.04
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Vergleichen Sie PRCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
58.76 | 3.21B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Stephens | Overweight |
| 2025-07-07 | Eingeleitet | Oppenheimer | Perform |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
Is PROCEPT BioRobotics Corporation a good long term investmentMassive portfolio appreciation - jammulinksnews.com
Evaluating PROCEPT BioRobotics (PRCT) Ahead of Q2 2025 Earnings: A Strategic Buy Opportunity in Surgical Robotics? - AInvest
What drives PROCEPT BioRobotics Corporation stock priceFree Investment Community - Autocar Professional
Procept Biorobotics shares rise 1.65% after-hours after announcing Q2 2025 earnings report date. - AInvest
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times
PROCEPT BioRobotics to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Quiver Quantitative
PROCEPT BioRobotics Corp (PRCT) stock falls 3.23% on July 21 - AInvest
PROCEPT BioRobotics Corporation Stock Analysis and ForecastFree Stock Market Real-Time Monitoring - printweek.in
PROCEPT BioRobotics Corp Shares Surge 3.68% Amid Analyst Predictions of 26.35% Upside - AInvest
What analysts say about PROCEPT BioRobotics Corporation stockExplosive returns - Autocar Professional
Nisa Investment Advisors LLC Purchases 270 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
Why PROCEPT BioRobotics Corporation stock is on top investor watchlistsExpert Trading Flow - Newser
how procept biorobotics corporation stock performs during market volatilityGroup Only Stock Signals - Newser
Morgan Stanley Lowers PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $68.00 - Defense World
Q2 EPS Estimate for PROCEPT BioRobotics Raised by Analyst - Defense World
Positive Outlook on PROCEPT BioRobotics Amid New Fee Schedule Developments for Aquablation - AInvest
Procept BioRobotics Receives Favorable CMS Updates and Reimbursement Stability - AInvest
Procept BioRobotics says Aquablation therapy assigned a Category I code - MSN
A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $68 to $85 - 富途牛牛
Teacher Retirement System of Texas Has $646,000 Stock Holdings in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 4.7% Following Analyst Downgrade - Defense World
How PROCEPT BioRobotics Corporation stock performs during market volatilityFree Smart Money Stock Analysis - Newser
Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionPredictable Return Stock Picks - Newser
What makes PROCEPT BioRobotics Corporation stock price move sharplyFree Real-Time Trading Opportunities - Newser
Procept BioRobotics Awarded Category 1 Code in 2026 Medicare Proposal - MarketScreener
Procept BioRobotics stock maintains Buy rating at BofA despite Medicare cuts By Investing.com - Investing.com South Africa
Procept BioRobotics stock maintains Buy rating at BofA despite Medicare cuts - Investing.com Nigeria
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule - Stock Titan
Buy Recommendation for Procept BioRobotics Supported by Favorable CMS Updates and Reimbursement Stability - TipRanks
PROCEPT BioRobotics Announces Category I CPT Code Assignment for Aquablation Therapy Effective January 1, 2026 - Nasdaq
Wells Fargo Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $75 - 富途牛牛
PROCEPT BioRobotics (NASDAQ:PRCT) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Procept BioRobotics initiated with an Overweight at Stephens - TipRanks
Insiders At PROCEPT BioRobotics Sold US$12m In Stock, Alluding To Potential Weakness - simplywall.st
New Analyst Forecast: $PRCT Given 'Perform' Rating - Quiver Quantitative
Oppenheimer Initiates PROCEPT BioRobotics(PRCT.US) With Hold Rating - 富途牛牛
Oppenheimer initiates coverage on Procept BioRobotics stock with Perform rating - Investing.com
Allspring Global Investments Holdings LLC Sells 305,956 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
Mirae Asset Global Investments Co. Ltd. Purchases 723 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) - Defense World
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):